PHYSIOTENS

This brand name is authorized in Australia, Croatia, Cyprus, Estonia, Finland, France, Germany, Lithuania, Malta, Poland, Romania, Tunisia, Turkey, UK.

Active ingredients

The drug PHYSIOTENS contains one active pharmaceutical ingredient (API):

1	Moxonidine UNII CC6X0L40GW - MOXONIDINE
	Moxonidine has been shown to bind selectively to the I1-imidazoline receptors in the brain stem. These imidazoline-sensitive receptors are concentrated in the rostral ventrolateral medulla, an area which is of crucial importance for central control of the peripheral sympathetic nervous system. The result of this effect on the I1-imidazoline receptors has been apparent in reduced activity in the sympathetic nerves. (demonstrated for cardiac, splanchnic and renal sympathetic nerves).
	Read more about Moxonidine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PHYSIOTENS Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C02AC05	Moxonidine	C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AC Imidazoline receptor agonists
Discover more medicines within C02AC05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	9019Q, 9020R
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	06172328, 06172340, 06172363
EE	Ravimiamet	1013779, 1013791
FI	Lääkealan turvallisuus- ja kehittämiskeskus	016642, 017806
FR	Base de données publique des médicaments	60993898, 68782718
GB	Medicines & Healthcare Products Regulatory Agency	13750, 13769, 13776, 147143, 176195, 176198
HR	Agencija za lijekove i medicinske proizvode	HR-H-577589830, HR-H-790867387
LT	Valstybinė vaistų kontrolės tarnyba	1003247, 1003249, 1011855, 1012537
MT	Medicines Authority	MA1507/01701, MA1507/01702, PI908/04701A, PI908/04702A
PL	Rejestru Produktów Leczniczych	100085105, 100085648, 100271285, 100271813, 100383015, 100384405, 100394958, 100404415, 100414508, 100414514, 100423460, 100435930, 100441280, 100451333
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68789001, W68789002, W68789003, W68790001, W68790002, W68790003
TN	Direction de la Pharmacie et du Médicament	5880096, 5880097
TR	İlaç ve Tıbbi Cihaz Kurumu	8699820090081, 8699820090104